Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Ming

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Artificial Cells, Nanomedicine, and Biotechnology|April 5, 2019
ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnologyThomas Ming Swi Chang
Artificial Cells, Nanomedicine, and Biotechnology|March 11, 2017
Translational feasibility of soluble nanobiotherapeutics with enhanced red blood cell functionsThomas Ming Swi Chang
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 23, 2003
In vitro enzyme kinetics of microencapsulated tyrosinaseBinglan Yu, Thomas Ming Swi Chang
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|July 28, 2004
Polyhemoglobin-tyrosinase, an oxygen carrier with murine B16F10 melanoma suppression properties: a preliminary reportBinglan Yu, Thomas Ming Swi Chang
Cancers|December 23, 2023
Superparamagnetic Artificial Cells PLGA-Fe<sub>3</sub>O<sub>4</sub> Micro/Nanocapsules for Cancer Targeted DeliveryTao Wang, Thomas Ming Swi Chang
Artificial Cells, Nanomedicine, and Biotechnology|June 7, 2018
Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusionChen Guo, Thomas Ming Swi Chang
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Biodegradable Polylactide Nanocapsules Containing Quercetin for In Vitro Suppression of Mouse B16F10 and Human Sk-Mel-28 Melanoma Cell LinesChenhui Zhao, Thomas Ming Swi Chang
Artificial Cells, Nanomedicine, and Biotechnology|June 2, 2021
A polymer-lipid membrane artificial cell nanocarrier containing enzyme-oxygen biotherapeutic inhibits the growth of B16F10 melanoma in 3D culture and in a mouse modelYun Wang, Thomas Ming Swi Chang
Melanoma Research|June 5, 2004
In vitro and in vivo effects of polyhaemoglobin-tyrosinase on murine B16F10 melanomaBinglan Yu, Thomas Ming Swi Chang
Journal of Pharmaceutical Sciences|March 5, 2004
Effects of long-term oral administration of polymeric microcapsules containing tyrosinase on maintaining decreased systemic tyrosine levels in ratsBinglan Yu, Thomas Ming Swi Chang
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Artificial Cells, Nanomedicine, and Biotechnology|April 5, 2019
ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnologyThomas Ming Swi Chang
Artificial Cells, Nanomedicine, and Biotechnology|March 11, 2017
Translational feasibility of soluble nanobiotherapeutics with enhanced red blood cell functionsThomas Ming Swi Chang
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 23, 2003
In vitro enzyme kinetics of microencapsulated tyrosinaseBinglan Yu, Thomas Ming Swi Chang
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|July 28, 2004
Polyhemoglobin-tyrosinase, an oxygen carrier with murine B16F10 melanoma suppression properties: a preliminary reportBinglan Yu, Thomas Ming Swi Chang
Cancers|December 23, 2023
Superparamagnetic Artificial Cells PLGA-Fe<sub>3</sub>O<sub>4</sub> Micro/Nanocapsules for Cancer Targeted DeliveryTao Wang, Thomas Ming Swi Chang
Artificial Cells, Nanomedicine, and Biotechnology|June 7, 2018
Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusionChen Guo, Thomas Ming Swi Chang
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Biodegradable Polylactide Nanocapsules Containing Quercetin for In Vitro Suppression of Mouse B16F10 and Human Sk-Mel-28 Melanoma Cell LinesChenhui Zhao, Thomas Ming Swi Chang
Artificial Cells, Nanomedicine, and Biotechnology|June 2, 2021
A polymer-lipid membrane artificial cell nanocarrier containing enzyme-oxygen biotherapeutic inhibits the growth of B16F10 melanoma in 3D culture and in a mouse modelYun Wang, Thomas Ming Swi Chang
Melanoma Research|June 5, 2004
In vitro and in vivo effects of polyhaemoglobin-tyrosinase on murine B16F10 melanomaBinglan Yu, Thomas Ming Swi Chang
Journal of Pharmaceutical Sciences|March 5, 2004
Effects of long-term oral administration of polymeric microcapsules containing tyrosinase on maintaining decreased systemic tyrosine levels in ratsBinglan Yu, Thomas Ming Swi Chang
Pageof 8